FDA Recognized Standards & DoC Guide
Last reviewed:
Build a standards evidence plan that connects FDA recognition scope, the tested device and declaration of conformity to the actual submission claims.
FDA recognition is specific to a standard and scope
A voluntary consensus standard can support a device submission when it addresses the relevant safety or performance question. FDA recognition is not the same as publication by ISO or IEC, nor does recognition mean the standard covers every aspect of the device. Start with the US FDA regulatory framework and the device's classification and special controls.
Search the FDA Recognized Consensus Standards Database for the exact designation and version. Read the recognition details, supplementary information, extent of recognition, limitations and any transition period. A familiar standard number without its edition and recognition scope is not a complete evidence decision.
Declaration of conformity versus general use
A declaration of conformity (DoC) is a formal submission statement supported by evidence that the device conforms to an FDA-recognized standard within the applicable scope. FDA's standards program explains that non-recognized, superseded or withdrawn standards cannot simply be used for a recognized-standard DoC; their use may instead need to be described under the general-use approach.
Follow FDA's guidance on appropriate use of consensus standards for the declaration and supporting documentation. Identify the device, standard, assessment basis and responsible signatory, and provide supplementary information where the recognized standard or guidance requires it. A laboratory certificate is not automatically the manufacturer's complete DoC.
Standards and testing evidence matrix
| Decision | Evidence to retain |
|---|---|
| Why this standard applies | Intended use, technology and risk-control question addressed |
| Which edition is accepted | Recognition record, extent, limitations and relevant transition |
| Which device was tested | Models, configurations, accessories, software and worst-case rationale |
| How conformity was established | Protocols, acceptance criteria, complete reports, deviations and conclusions |
| What remains outside the standard | Additional testing, clinical evidence or device-specific justification |
Address deviations explicitly. Partial recognition does not authorize a blanket claim of full FDA acceptance. Reconcile test configurations with the final labeling, risk file and manufacturing specification; a design or supplier change may invalidate an old report's applicability.
Submission and lifecycle handoff
Map the standards matrix to the appropriate 510(k), De Novo or PMA sections and eSTAR attachments. Use a focused Pre-Submission where a novel test method or evidence strategy needs agency feedback. Recognition and use of a standard do not guarantee substantial equivalence or approval.
Retain the underlying data within controlled QMSR records and assess new editions, recognition changes and device modifications through change control. Distinguish a newly published ISO edition from an FDA-recognized edition before commissioning repeat testing or claiming a declaration transition.
Example: ISO 10993 biological evaluation
Our FDA biocompatibility guide shows how this review works for ISO 10993-1:2025, which FDA partially recognizes. Check the specific exclusions, implementation notes and declaration transition before selecting the assessment approach. Keep the standard decision connected to the finished device and biological evaluation records.
Plan your submission with Pure Global
Plan your device registration, local representation and ongoing compliance with Pure Global.

Frequently asked questions
No. Check the FDA database for the exact standard designation, edition and recognition scope. Publication by a standards organization alone does not establish FDA recognition or acceptance of every clause.
It may support an appropriately justified general-use evidence approach, but it cannot automatically be presented as a formal declaration to an FDA-recognized standard. Explain its relevance, methods, results and any gaps using current guidance.
No. Retain the data and records supporting the conformity statement and provide required supplementary information. The declaration must correspond to the actual device, standard scope and testing evidence rather than replace evidence that does not exist.
Single Process,
Multiple Markets
When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us










